The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A real-world survival outcome comparison of a minority-rich population with DLBCL treated with CAR-T cell therapy vs. autologous stem cell transplant.
 
Ahmed Abbasi
No Relationships to Disclose
 
Christopher Lawson
No Relationships to Disclose
 
Melissa Rivas
No Relationships to Disclose
 
Bradley Rockwell
No Relationships to Disclose
 
Sonya Henry
No Relationships to Disclose
 
Vita Berani
No Relationships to Disclose
 
Mendel Goldfinger
No Relationships to Disclose
 
Amit Verma
Leadership - Cardiff Oncology (I); CytomX Therapeutics (I)
Stock and Other Ownership Interests - Roshon Therapeutics; Stelexis Therapeutics; ThromboGenics
Honoraria - Stelexis Therapeutics
Consulting or Advisory Role - Janssen; Keros Therapeutics; Ryvu Therapeutics
Research Funding - Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Prelude Therapeutics; Ryvu Therapeutics
 
Aditi Shastri
Honoraria - Great Debates and Updates; Peerview
Consulting or Advisory Role - Kymera; Ryvu Therapeutics
Research Funding - Kymera; Ryvu Therapeutics
 
Noah Kornblum
No Relationships to Disclose
 
Kira Gritsman
No Relationships to Disclose
 
Alejandro Sica
No Relationships to Disclose